Cerebrospinal Fluid Concentrations of Functionally Important Amino Acids and Metabolic Compounds in Patients with Mild Cognitive Impairment and Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1660-2862|7|4|251-259

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.7, Iss.4, 2010-05, pp. : 251-259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

S-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 7, Iss. 6, 2010-06 ,pp. : 373-378

Karger

Access to resources Recommend Favorite

Peripheral Inflammatory Cytokines as Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment

By  

Neurodegenerative Diseases, Vol. 4, Iss. 6, 2007-10 ,pp. : 406-412

Karger

Access to resources Recommend Favorite

Inability of Plasma and Urine F2A-Isoprostane Levels to Differentiate Mild Cognitive Impairment from Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 7, Iss. 1-3, 2010-03 ,pp. : 139-142

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Biomarkers Predict Clinical Evolution in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment

By  

Neurodegenerative Diseases, Vol. 16, Iss. 1-2, 2016-0 ,pp. : 69-76

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Profile of Amyloid β Peptides in Patients with Alzheimer’s Disease Determined by Protein Biochip Technology

By  

Neurodegenerative Diseases, Vol. 1, Iss. 4-5, 2004-11 ,pp. : 231-235

Karger

Access to resources Recommend Favorite